Our mission

Well-known brands, high-quality products,
Easy access and strong partners

Pioneering the future of cannabis

At the core of our mission is the development of powerful brands and the delivery of high-quality cannabis products. We believe in setting industry standards for excellence and reliability.

We are dedicated to simplifying the pathway to modern cannabis-based therapies. Our efforts are focused on removing barriers to ensuring access to modern therapy

Strong partnerships are fundamental to our success. By collaborating closely with pharmacies and suppliers, we enhance the supply chain’s efficiency and reliability, benefiting all stakeholders involved.

We position ourselves as the primary resource and advocate for medical cannabis. Our expertise and dedication make us the first point of contact for reliable information and products.

Our vision extends beyond local markets to international horizons. We are committed to unlocking global opportunities, driving growth, and facilitating access to cannabis products worldwide.


From wholesaler to platform provider

2017: Found

In spring 2017, the legal regulations to facilitate access to medicinal cannabis in Germany came into force.

At the same time, Jakob and Benedikt Sons founded Cansativa GmbH together with their father.

2018: Wholesale

Cansativa began its wholesale activities in May 2018, operating from its first premises in Fechenheim, Frankfurt am Main. This early phase laid the groundwork for the company’s future endeavors.

2019: Import and production

In 2019, the company expanded its operations and moved to a new location in Mörfelden-Walldorf, near Frankfurt Airport.

Over time, the facility has been extensively upgraded to store and distribute large quantities of raw materials, semi-finished and finished products.

In addition to storage space, the premises in Mörfelden-Walldorf also include a clean room facility for the final processing and bottling of cannabis flowers.

What began as a wholesale business developed into the company’s own packaging and processing facility.

2020: German cannabis

In 2020, Cansativa GmbH was awarded the contract by the Federal Republic of Germany to handle the distribution logistics for the cannabis agency set up by the Federal Institute for Drugs and Medical Devices (BfArM).

Since then, the company has been responsible for the distribution of cannabis grown in Germany as the exclusive partner of the German government.

2021: Platform

Cansativa has developed into a central platform for pharmacies and suppliers from all over the world.

In addition to its wholesale offering, the company focuses in particular on supporting pharmacies and suppliers to grow in the market.

Cansativa is a leading provider of product information and availability data and as such is integrated into numerous pharmacy and specialist information systems.

2022: Own brands

In 2022, Cansativa established its own brand portfolio with the two medicinal cannabis brands AMICI and N!CE.

In addition, Cansativa positioned itself as a strategic partner of successful international brands such as Peace Naturals (Cronos Inc.) and MedMen.

2023: Internationalization

The company has established strong international supply chains for its portfolio.

Cansativa supports the growth of key European and international markets. The first exports were already made in 2023.

Our experts
for your business

Cansativa provides elaborate knowledge within the industry with our diverse team of experts from various fields.

We develop a dependable and diversified product and service landscape alongside our international partners, governmental bodies, administrators and customers.

Our team enables an innovative future for a new industry of enormous potential.

⸻ our USP

Industry leader with excellence

Average market share of 20% with a total sales volume of 2.5 t in 2022

Brand and product diversity

Continuous portfolio expansion with +400 SKU

Suppliers and
Connecting customers

Over 40+ international suppliers and +2k active customers

Exclusive government contracts

With a volume of over +10 tons for domestic supply


Industry-leading cannabis platform

Leading the way
for the industry

With net sales of EUR +17 million in 2023

We are pioneers.

We are executors. We are enablers.

As founders, Jakob and Benedikt complement each other with their different professional backgrounds.

The key to our success is the diversity of our talents and perspectives, combined with a strong pioneering and entrepreneurial spirit and a strong shared value system. This enables us to master the various challenges of our market in a responsible and future-oriented way.

Together with a team of talented, motivated and visionary colleagues, we are pioneers of a strong industry. Together, we want to pave the way for easy and safe access to cannabis and make Germany the pioneer of a European cannabis ecosystem.

Explore Our Cannabis Briefing

Stay ahead with the latest insights in medical cannabis, political decisions, industry news, and research advances.

⸻ Newsletter

Stay informed!

Our newsletter is designed to keep you informed and ahead in the rapidly evolving world of medical cannabis. The Cannabis Briefing is your essential resource for the latest research findings, regulatory updates, market trends, and advocacy efforts shaping the future of cannabis.

Public Affairs – fostering knowledge transfer between industry and public stakeholders

Our public affairs team aspires to be a leader in responsibility and transparency in the public policy process regarding medicinal cannabis and the cannabis legalization for adult-use.

We are committed to open and transparent discussions that advance the discourse on facts, create a safe and better future for our partners, customers and patients in order to promote trust in the European cannabis industry.

We are proud member of key associations within the cannabis industry, furthering our commitment to excellence and collaboration. As a board member (“Vorstandsmitglied”) of the BPC (Federal Association of Pharmaceutical Cannabinoid Companies), we actively contribute to shaping the voice of pharmaceutical cannabinoid companies in Germany. Furthermore, as a supporting member (“Fördermitglied”) of the VCA (Association of Cannabis Supplying Pharmacies e.V.), we are at the forefront of ensuring quality cannabis care through pharmacies. These partnerships underscore our dedication to leading the industry forward with integrity and expertise.

In addition to our focus on ethical business practices, we prioritize compliance with all relevant laws and regulations in the industry, including registering our lobbying activities and working in accordance with state code of conduct.

Find our latest publications and political letters here.


Download Center

Comprehensive information about the Cansativa Group

Discover our press kit to get a comprehensive insight into the Cansativa Group. This kit, in PDF format, provides detailed insights into our company, including key information, awards and portraits of the founders.

Designed for journalists, bloggers and media professionals, it provides a comprehensive overview of our pioneering role in the cannabis industry, our vision and the latest developments. In the media kit you will find the most important facts, photos and logos.

Media kit